Sector ratings Sanofi

Stocks

Market Closed - Euronext Paris Other stock markets 19:55:00 10/07/2026 +04			5-day change	1st Jan Change
76.23 ^EUR	-0.33%		+0.55%	-7.85%

07-10	Sanofi Receives Fda Approval for Subcutaneous Sarclisa Escena Administered Via On-Body Injector	CI
07-10	Sanofi Wins US FDA Approval for Subcutaneous Sarclisa Escena in Multiple Myeloma	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Fundamentals
SANOFI	105B	AA
ELI LILLY AND COMPANY	1,060B	A
JOHNSON & JOHNSON	619B	BBB
ABBVIE INC.	438B	AA	-
ROCHE HOLDING AG	333B	AA
NOVARTIS AG	282B	AAA
ASTRAZENECA PLC	267B	A
NOVO NORDISK A/S	218B	A
AMGEN INC.	196B	A
GILEAD SCIENCES, INC.	161B	AA
PFIZER INC.	138B	A
VERTEX PHARMACEUTICALS INCORPORATED	123B	AA
BRISTOL-MYERS SQUIBB COMPANY	118B	A
GSK PLC	105B	AA
CHUGAI PHARMACEUTICAL CO., LTD.	75.29B	AA
BAYER AG	56.29B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	54.27B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	52.42B	AA
HALEON PLC	42.8B	AA
ALNYLAM PHARMACEUTICALS, INC.	39.89B	AA
Average	224.14B	AA
Weighted average by Cap.		AA